From diagnosis methods to management of comorbid infections, new lung cancer protocols adaptable for various conditions ...

Australia has launched its first lung cancer screening program, which targets current and recent smokers with biennial ...

The treatment marks the only targeted oral treatment in patients with non–small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations.

Lung cancer can be hereditary, with mutations in the EGFR and KRAS genes potentially playing a role. Smoking, however, is by far the biggest risk factor.

Dr. W. Kimryn Rathmell started as new chief executive officer of Ohio State University's Comprehensive Cancer Center - James.

A new study has opened in Manchester which could improve screening and early detection of lung cancer for high-risk Hodgkin ...

Metastatic non-small cell lung cancer treatment and management requires a team effort. Here are the healthcare professionals to consider adding to your team.

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that ...

Eight years after it was established partly by AstraZeneca, Dizal Pharmaceuticals has gained its first FDA approval, winning an accelerated nod for Zegfrovy (sunvozertinib) to become the only ...

IMAGES BELOW] Complete resolution maintained at 6 months in first patient treated with BriaCell’s Bria-OTS in Phase 1/2a ...

It all started with frequent stomach aches about four years ago,” Mrs Agnes Acholi recalled. “From there, each episode of ...